Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.

Sarah K BallouTed J KaptchukWilliam HirschJudy NeeJohanna IturrinoKathryn T HallJohn M KelleyVivian ChengIrving KirschEric JacobsonLisa ConboyAnthony LemboRoger B Davis

Published in: Trials (2017)

ClinicalTrials.gov, identifier: NCT02802241 . Registered on 14 June 2016.

Keyphrases

irritable bowel syndrome
double blind
open label
phase iii
clinical trial
placebo controlled
phase ii
study protocol
randomized controlled trial
replacement therapy